CRISPR Therapeutics AG (CRSP) stock price positioned at -23.30% from the 52 week high and situated at 84.59% from 52 week low. 1214738 shares traded on hands while it’s an average volume stands with 1.22M shares. In last trading session, the stock received negative focus on shares from Traders. The stock has performed -2.32% and it registered share value at $56.76 in recent trade transaction.

VOLATILITY FACTOR: The stock remained 6.28% volatile in recent week and indicated 4.76% volatility in last month. The Company’s beta coefficient sits at 3.2. Beta factor measures the amount of market risk associated with market trade. Higher the beta discloses more riskiness and lower the beta lower the risk. ATR value of 2.77 measure stock volatility. The Average True Range is an exponential moving average (14-days) of the True Ranges.

PROFITABILITY RATIOS: The company’s net profit margin is 23.10%. It measures how much out of every dollar of sales a company actually keeps in earnings. Operating Margin is seen at 16.10%. Return on Assets (ROA) an indicator of how profitable a company is relative to its total assets, is 9.60%. Return on Equity (ROE) is 11.70% and Return on Investment (ROI) is 4.90%.


CRISPR Therapeutics AG (CRSP) is Switzerland based company. Currently it has a market worth of $3.60B. Using market capitalization to show the size of a company is important because company size is a basic determinant of various characteristics in which investors are interested, including risk. P/E ratio is noted at 58.46. P/E is a popular valuation ratio of a company’s current share price compared to its per-share earnings (trailing twelve months). P/S ratio of 12.42 reflects the value placed on sales by the market. P/B ratio is 3.47. P/B is used to compare a stock’s market value to its book value.


CRISPR Therapeutics AG (CRSP) has year to date performance of -6.81% and weekly performance of -1.71%. The stock has been moved at 16.98% over the last six months and 77.43% throughout last twelve months. The stock has performed -2.34% around last thirty days, and changed -3.02% over the last three months.

ANALYSTS VIEWS: The current analyst consensus rating clocked at 2.2 on company shares based on data provided from FINVIZ. (1.0 Strong Buy, 2.0 Buy, 3.0 Hold, 4.0 Sell, 5.0 Strong Sell). Analysts expected the stock to attain $75.96 price in coming 52-week period.


The Relative Strength Index (RSI) was developed by J. Welles Wilder, and it reading fluctuates between 0 and 100. The RSI is a momentum oscillator that measures the speed and change of stock price movements. Generally, the when RSI falls below 30 then stock considered to be oversold and overbought when it moves above 70. The normal reading of a stock will fall in the range of 30 to 70. RSI can be used to detect general trends as well as finding divergences and failure swings. Now CRSP has RSI reading of 48.84.

Source link